Literature DB >> 28736341

TFOS DEWS II iatrogenic report.

José Alvaro P Gomes1, Dimitri T Azar2, Christophe Baudouin3, Nathan Efron4, Masatoshi Hirayama5, Jutta Horwath-Winter6, Terry Kim7, Jodhbir S Mehta8, Elisabeth M Messmer9, Jay S Pepose10, Virender S Sangwan11, Alan L Weiner12, Steven E Wilson13, James S Wolffsohn14.   

Abstract

Dry eye can be caused by a variety of iatrogenic interventions. The increasing number of patients looking for eye care or cosmetic procedures involving the eyes, together with a better understanding of the pathophysiological mechanisms of dry eye disease (DED), have led to the need for a specific report about iatrogenic dry eye within the TFOS DEWS II. Topical medications can cause DED due to their allergic, toxic and immuno-inflammatory effects on the ocular surface. Preservatives, such as benzalkonium chloride, may further aggravate DED. A variety of systemic drugs can also induce DED secondary to multiple mechanisms. Moreover, the use of contact lens induces or is associated with DED. However, one of the most emblematic situations is DED caused by surgical procedures such as corneal refractive surgery as in laser-assisted in situ keratomileusis (LASIK) and keratoplasty due to mechanisms intrinsic to the procedure (i.e. corneal nerve cutting) or even by the use of postoperative topical drugs. Cataract surgery, lid surgeries, botulinum toxin application and cosmetic procedures are also considered risk factors to iatrogenic DED, which can cause patient dissatisfaction, visual disturbance and poor surgical outcomes. This report also presents future directions to address iatrogenic DED, including the need for more in-depth epidemiological studies about the risk factors, development of less toxic medications and preservatives, as well as new techniques for less invasive eye surgeries. Novel research into detection of early dry eye prior to surgeries, efforts to establish appropriate therapeutics and a greater attempt to regulate and oversee medications, preservatives and procedures should be considered.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Contact lens; Cosmetic; Drug related adverse reactions; Drug related side effects; Drug toxicity; Dry eye; Iatrogenic disease; Surgery

Mesh:

Year:  2017        PMID: 28736341     DOI: 10.1016/j.jtos.2017.05.004

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   5.033


  59 in total

Review 1.  TFOS DEWS II Tear Film Report.

Authors:  Mark D P Willcox; Pablo Argüeso; Georgi A Georgiev; Juha M Holopainen; Gordon W Laurie; Tom J Millar; Eric B Papas; Jannick P Rolland; Tannin A Schmidt; Ulrike Stahl; Tatiana Suarez; Lakshman N Subbaraman; Omür Ö Uçakhan; Lyndon Jones
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

2.  A novel ophthalmic latanoprost 0.005% nanoemulsion: a cytotoxicity study.

Authors:  Julia Tau; María Silvia Passerini; Melina Del Papa; Alejandro Aguilar; Alejandro Berra
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-01-11       Impact factor: 3.117

3.  The Effect of Past Cataract Surgery within the Medium to Long-Term Period on Patients with Dry Eye Disease.

Authors:  Lei Siew; Louis Tong
Journal:  J Clin Med       Date:  2022-02-13       Impact factor: 4.241

4.  Comparative Evaluation of Clinical Methods of Tear Film Stability Assessment: A Randomized Crossover Trial.

Authors:  Michael T M Wang; Jennifer P Craig
Journal:  JAMA Ophthalmol       Date:  2018-03-01       Impact factor: 7.389

5.  Shifting the IGF-axis: An age-related decline in human tear IGF-1 correlates with clinical signs of dry eye.

Authors:  Roshni Patel; Meifang Zhu; Danielle M Robertson
Journal:  Growth Horm IGF Res       Date:  2018-02-06       Impact factor: 2.372

6.  Effect of brimonidine, an α2 adrenergic agonist, on human meibomian gland epithelial cells.

Authors:  Xi Han; Yang Liu; Wendy R Kam; David A Sullivan
Journal:  Exp Eye Res       Date:  2018-02-13       Impact factor: 3.467

7.  Comparison of BAK-preserved latanoprost and polyquad-preserved travoprost on ocular surface parameters in patients with glaucoma and ocular hypertension.

Authors:  Omer Ersin Muz; Kenan Dagdelen; Tuncay Pirdal; Mete Guler
Journal:  Int Ophthalmol       Date:  2021-07-14       Impact factor: 2.031

8.  Association of the Indoor Environment With Dry Eye Metrics.

Authors:  Amy Huang; Julia Janecki; Anat Galor; Sarah Rock; Dhariyat Menendez; Abigail S Hackam; Bennie H Jeng; Naresh Kumar
Journal:  JAMA Ophthalmol       Date:  2020-08-01       Impact factor: 7.389

9.  Clinical Features, Risk Factors, and Therapy of Epithelial Keratitis after Cataract Surgery.

Authors:  Yani Wang; Dongfang Li; Wenjie Su; Yunhai Dai
Journal:  J Ophthalmol       Date:  2021-05-06       Impact factor: 1.909

Review 10.  Evidence of Polyphenols Efficacy against Dry Eye Disease.

Authors:  Gaia Favero; Enrico Moretti; Kristína Krajčíková; Vladimíra Tomečková; Rita Rezzani
Journal:  Antioxidants (Basel)       Date:  2021-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.